scholarly journals Early High-Dose Continuous Veno-Venous Hemofiltration Alleviates the Alterations of Cd4+ T Lymphocyte Subsets in Septic Patients Combined With Acute Kidney Injury

Author(s):  
Beibei Jin ◽  
Da Cao ◽  
Ning Yang ◽  
Ling Wang ◽  
Ruifang Li ◽  
...  

Abstract BackgroundThis study aims to observe the changes in CD4+ T lymphocyte subsets in septic patients combined with acute kidney injury and the effect of early high-dose CVVH on CD4+ T lymphocyte subsets. MethodsEnrolled septic patients combined with acute kidney injury were randomly divided into CVVH (n = 50) and conventional treatment (non-CVVH, n = 53) groups. Healthy volunteers (n = 21) were enrolled. CVVH was initiated within 12 h of intensive care unit (ICU) admission with the doses of 35 ~ 60 mL/kg/h and maintained for at least 72 h. Th1, Th2, Th17 and Treg were measured by flow cytometry on days 1, 3 and 7 of ICU admission. Sequential organ failure assessment (SOFA) scores were calculated. ResultsTh1 percentages and Th1/Th2 ratios were lower, and Th2, Th17 and Treg percentages and Th17/Treg ratios were higher in patients with sepsis, when compared to healthy volunteers (all P < 0.05). Early high-dose CVVH treatment significantly increased Th1 percentages and Th1/Th2 ratios, and significantly decreased Th2, Th17 and Treg percentages and Th17/Treg ratios, when compared to non-CVVH treatment (all P < 0.05). Th1 percentages and Th1/Th2 ratios were negatively correlated with SOFA scores, while Th2, Th17 and Treg percentages and Th17/Treg ratios were positively correlated with SOFA scores (all P < 0.05). Patients with sepsis in the CVVH group had significantly lower SOFA scores on day 7 of ICU admission and a shorter ICU stay when compared to those in the non-CVVH group (P < 0.05). However, the difference in 28-day mortality was not significant between the CVVH and non-CVVH groups (22.0% vs. 37.7%, P = 0.104).ConclusionSeptic patients combined with acute kidney injury exhibit the different alterations of CD4+ T lymphocyte subsets. Early high-dose CVVH treatment could alleviate the alterations, which may be one of factors associated with the improvement of sepsis severity, but do not significantly decrease the 28-day mortality.

2021 ◽  
Author(s):  
Guanglan Li ◽  
Yu Zhang ◽  
Ganyuan He ◽  
Wenke Hao ◽  
Wenxue Hu

Abstract Objective: Acute kidney injury (AKI) is a frequent complication of sepsis patients and is associated with high morbidity and mortality. Early recognition of sepsis-associated AKI (SA-AKI) is crucial to provide supportive treatment and improve prognosis. Thus, the objective is to analyze the early discriminative predictive information regarding T lymphocyte subsets of SA-AKI.Methods: We evaluated the relationships of T lymphocyte subsets and clinical parameters of sepsis patients, and assessed their potential roles in SA-AKI diagnosis. The following T lymphocyte subsets were studied: total T lymphocyte (CD3+), helper T lymphocyte (T helper, CD3+CD4+), cytotoxic T lymphocyte (CTL, CD3+CD8+), totally activated T lymphocyte (CD3+HLADR+), early activated T lymphocyte (CD4+CD69+, CD8+CD69+), regulatory T lymphocyte (Treg, CD4+CD25+, CD8+CD25+).Results: A total of 171 patients with sepsis were enrolled. The incidence of AKI was 80.1%. The percentages of total T lymphocyte, CTL, and totally activated T lymphocyte of SA-AKI patients were lower than those of sepsis patients without AKI (61.95±19.65 % vs 68.80±18.57 %, 19.95±17.22 % vs 26.48±18.31 %, 19.00±14.21 % vs 30.88±28.86 %, respectively, P<0.05). There were no significant differences in the percentages of T helper, early activated T lymphocyte, and Tregs between SA-AKI group and non-SA-AKI group. Univariate logistic regression analysis showed that percentages of total T lymphocyte, CTL, and totally activated T lymphocyte were protective factors for SA-AKI. Multivariate logistic regression analysis revealed that percentage of totally activated T lymphocyte had a negative association with SA-AKI independently (OR: 0.952, 95% CI: 0.926-0.978, P=0.000). Moreover, ROC analysis showed that total T lymphocyte, CTL, and totally activated T lymphocyte had discriminatory abilities, with areas under the curve (AUC) value of 0.638, 0.615, and 0.661, respectively (P<0.05). Conclusions: Impaired total T lymphocyte, CTL, and totally activated T lymphocyte could contribute to early diagnosis for SA-AKI.


2019 ◽  
Vol 8 (4) ◽  
pp. 447 ◽  
Author(s):  
Tak Kyu Oh ◽  
In-Ae Song ◽  
Young-Tae Jeon ◽  
You Hwan Jo

Exposure to dyschloremia among critically ill patients is associated with an increased risk of acute kidney injury (AKI). We aimed to investigate how fluctuations in serum chloride (Cl−) are associated with the development of AKI in critically ill patients. We retrospectively analyzed medical records of adult patients admitted to the intensive care unit (ICU) between January 2012 and December 2017. Positive and negative fluctuations in Cl− were defined as the difference between the baseline Cl- and maximum Cl- levels and the difference between the baseline Cl− and minimum Cl− levels measured within 72 h after ICU admission, respectively. In total, 19,707 patients were included. The odds of developing AKI increased 1.06-fold for every 1 mmol L−1 increase in the positive fluctuations in Cl− (odds ratio: 1.06; 95% confidence interval: 1.04 to 1.08; p < 0.001) and 1.04-fold for every 1 mmol L−1 increase in the negative fluctuations in Cl− (odds ratio: 1.04; 95% confidence interval: 1.02 to 1.06; p < 0.001). Increases in both the positive and negative fluctuations in Cl- after ICU admission were associated with an increased risk of AKI. Furthermore, these associations differed based on the functional status of the kidneys at ICU admission or postoperative ICU admission.


2009 ◽  
Vol 32 (5) ◽  
pp. 544-551 ◽  
Author(s):  
J. Gerstoft ◽  
K. Bentsen ◽  
E. Scheibel ◽  
J. Dalsgård-Nielsen ◽  
J. Gormsen ◽  
...  

2016 ◽  
Vol 16 (5) ◽  
pp. 577-585 ◽  
Author(s):  
Hongjin Chu ◽  
Fengcai Du ◽  
Lixin Jiang ◽  
Zhixin Wang ◽  
Zhaohua Gong ◽  
...  

Objective: To investigate the efficacy of cytokine-induced killer cell-based immunotherapies in patients with advanced malignant solid tumors and the difference in clinical efficiency among 3 kinds of cytokine-induced killer cell-based immunotherapies. Methods: One hundred forty-six cases with advanced solid tumor, 230 cycles of cytokine-induced killer cell-based immunotherapies, were involved in this study. T-lymphocyte subsets, carcinoembryonic antigen, and adverse reactions were recorded. Results: CD3+ T lymphocyte, Th, NKT, and Th/Tc were increased after cytokine-induced killer cell-based treatment, from 55.67 ± 3.64 to 84.12 ± 5.15, 26.56 ± 4.47 to 42.76 ± 3.68, 1.82 ± 0.58 to 7.08 ± 0.92, 0.79 ± 3.64 to 1.35 ± 0.20, respectively ( P < .001). Carcinoembryonic antigen was decreased from 398.39 ± 219.16 to 127.26 ± 153.41 ( P < .001). Difference values were greater than 0 ( P < .001). Difference value of carcinoembryonic antigen was obviously less than 0 ( P < .001). There was no obvious difference in all variations between cytokine-induced killer cell and DC+CIK groups ( P > .05). The highest amount of CD3+ T lymphocyte and Th was recorded after at least 4 cycles of immunotherapy. And CD8+ T/CD4+ T also began to decrease after 4 cycles of immunotherapy. Difference value of T lymphocyte and Tc of patients with surgery is higher than that of patients without surgery. Conclusion: Cytokine-induced killer cell-based immunotherapy is capable of increasing T-lymphocyte subsets, recovering cellular immunity without severe side effects, and is suitable for different kinds of solid cancer. Clinical efficiency of cytokine-induced killer cell-based immunotherapy is influenced by many factors such as surgery, stage.


2007 ◽  
Vol 13 (5) ◽  
pp. 1031-1042 ◽  
Author(s):  
M.F. Nassar ◽  
N.T. Younis ◽  
A.G. Tohamy ◽  
D.M. Dalam ◽  
M.A. El Badawy

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Hao Kang ◽  
Yunbo Wei ◽  
Ming Liu ◽  
Di Yu ◽  
Yong Tao

Abstract Background The purpose of this study is to investigate the aqueous humor (AH) T lymphocyte subsets and cytokines of acute retinal necrosis (ARN) to elucidate the immunologic inflammatory features of this disorder. Methods Three patients with ARN infected with varicella zoster virus (VZV) who underwent multiple intravitreal injections of ganciclovir were enrolled in this study. The control group consisted of four non-infectious patients with acute anterior uveitis (AAU). Flow cytometric analysis was performed on the lymphocyte subsets from the AH and peripheral blood (PB) samples during the active phase of intraocular inflammation. Five inflammatory cytokines were measured in each AH sample and various clinical characteristics were also assessed. Results VZV deoxyribonucleic acid (DNA) was detected by real-time polymerase chain reaction (PCR) in AH from all the ARN patients, who showed higher CD8+ T lymphocytes population in AH than the AAU patients (p = 0.006). CD4/CD8 ratios of T lymphocytes and the percentage of CD8 + CD25+ T lymphocytes in AH were significantly lower in ARN than in AAU (p = 0.006; p = 0.012). In the ARN patients, the percentages of CD4+ and CD8+ T lymphocytes in AH were higher than those found in PB. The percentage of CD4 + CD25+ T lymphocytes in AH was significantly higher than the proportion in PB in the AAU patients (p = 0.001). Immunoregulatory cytokine Interleukin-10 in AH was significantly elevated in the ARN patients in comparison with the case of the AAU patients (p = 0.036). In ARN, the copy number of VZV DNA in AH positively correlated with the percentage of CD8+ T lymphocytes in AH and negatively correlated with the CD4/CD8 ratio in AH during the course of disease treatment (p = 0.009, r = 0.92; p = 0.039, r = − 0.834). Conclusion The ARN patients caused by VZV had different intraocular T lymphocyte subsets and cytokines profile than those of the non-infectious patients. High percentages of CD8+ T lymphocytes and low CD4/CD8 T cell ratios may be a potential biomarker for diagnosis of viral-infectious uveitis. T lymphocytes examination at the inflammatory sites has the potential to become a useful research tool for differentiating viral and non-viral uveitis.


2021 ◽  
Vol 14 (4) ◽  
pp. e241462
Author(s):  
Suchi Anindita Ghosh ◽  
Jean Patrick ◽  
Kyaw Zin Maw

A 77-year-old man was admitted with severe acute kidney injury and nephrotic syndrome. He was started on eltrombopag for chronic idiopathic thrombocytopenic purpura 6 weeks earlier. An ultrasound of the kidneys was normal and an auto-antibody screen was negative. The use of the Naranjo adverse drug reaction probability scale indicated a probable relationship (score of 5) between the patient’s development of acute renal failure and eltrombopag therapy. Literature review identified only one other case of nephrotic syndrome and acute kidney injury associated with eltrombopag therapy in which a kidney biopsy revealed focal segmental glomerulosclerosis. Due to the challenges faced during the prevailing SARS-CoV-2 pandemic and persistent low platelet counts a renal biopsy was not undertaken. On stopping eltrombopag, the patients renal function stabilised and he successfully went into remission following treatment with high dose corticosteroids and diuretics. This report of a serious case of reversible renal failure and nephrotic syndrome after treatment with eltrombopag may serve to inform clinicians about the possible severe renal adverse effects of eltrombopag before its commencement for future use.


2021 ◽  
Vol 8 ◽  
pp. 205435812110277
Author(s):  
Tyler Pitre ◽  
Angela (Hong Tian) Dong ◽  
Aaron Jones ◽  
Jessica Kapralik ◽  
Sonya Cui ◽  
...  

Background: The incidence of acute kidney injury (AKI) in patients with COVID-19 and its association with mortality and disease severity is understudied in the Canadian population. Objective: To determine the incidence of AKI in a cohort of patients with COVID-19 admitted to medicine and intensive care unit (ICU) wards, its association with in-hospital mortality, and disease severity. Our aim was to stratify these outcomes by out-of-hospital AKI and in-hospital AKI. Design: Retrospective cohort study from a registry of patients with COVID-19. Setting: Three community and 3 academic hospitals. Patients: A total of 815 patients admitted to hospital with COVID-19 between March 4, 2020, and April 23, 2021. Measurements: Stage of AKI, ICU admission, mechanical ventilation, and in-hospital mortality. Methods: We classified AKI by comparing highest to lowest recorded serum creatinine in hospital and staged AKI based on the Kidney Disease: Improving Global Outcomes (KDIGO) system. We calculated the unadjusted and adjusted odds ratio for the stage of AKI and the outcomes of ICU admission, mechanical ventilation, and in-hospital mortality. Results: Of the 815 patients registered, 439 (53.9%) developed AKI, 253 (57.6%) presented with AKI, and 186 (42.4%) developed AKI in-hospital. The odds of ICU admission, mechanical ventilation, and death increased as the AKI stage worsened. Stage 3 AKI that occurred during hospitalization increased the odds of death (odds ratio [OR] = 7.87 [4.35, 14.23]). Stage 3 AKI that occurred prior to hospitalization carried an increased odds of death (OR = 5.28 [2.60, 10.73]). Limitations: Observational study with small sample size limits precision of estimates. Lack of nonhospitalized patients with COVID-19 and hospitalized patients without COVID-19 as controls limits causal inferences. Conclusions: Acute kidney injury, whether it occurs prior to or after hospitalization, is associated with a high risk of poor outcomes in patients with COVID-19. Routine assessment of kidney function in patients with COVID-19 may improve risk stratification. Trial registration: The study was not registered on a publicly accessible registry because it did not involve any health care intervention on human participants.


Sign in / Sign up

Export Citation Format

Share Document